Angiotech in search of AAA stent-graft
This article was originally published in The Gray Sheet
Executive Summary
University of British Columbia will license to pharmaceutical firm its next-generation stent-endograft coating technology to treat abdominal aortic aneurysms, Angiotech notes March 17. Jointly developed, the drug coating promotes fibrous (scar) tissue growth and creates a biologic anchor for the stent. Angiotech has begun seeking device development partners...